Goods & Services

Surgical, medical instruments and apparatus.

Goods & Services

Pharmaceutical preparations for nutrition, namely, infusion solutions for central and peripheral intravenous nutritional therapy and infusion solutions for central and peripheral intravenous parenteral nutrition.

Goods & Services

Pharmaceutical preparations, namely organic phosphate for treating nutritional conditions; Pharmaceutical preparations, namely, infusion solutions containing organic phosphate; Nutritional supplement containing organic phosphate; Intravenous fluids containing organic phosphate used for rehydration, nutrition and the delivery of pharmaceutical preparations; Nutritional supplements containing sodium glycerophosphate for parenteral nutrition in adult and pediatric patients when oral or enteral nutrition is not possible, insufficient, or contraindicated; Pharmaceutical preparations, namely, intravenous fluids to correct hypophosphatemia in adult and pediatric patients when oral or enteral replacement is not possible, insufficient, or contraindicated

Abstract

A syringe assembly includes a syringe with a tamper-evident cap over the Luer connection. The cap has a proximal end with an opening, a distal end, and a frangible connection between them. The frangible connection breaks under force, leaving the proximal end engaged with the syringe. An RFID tag on the syringe communicates with an RFID reader.

IPC Classes  ?

• A61M 5/50 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
• A61J 1/20 - Arrangements for transferring fluids, e.g. from vial to syringe
• A61M 5/31 - Syringes Details
• A61M 5/32 - NeedlesDetails of needles pertaining to their connection with syringe or hubAccessories for bringing the needle into, or holding the needle on, the bodyDevices for protection of needles
• B65B 3/00 - Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans or jars

Goods & Services

Pharmaceutical preparations; medical preparations; dietetic substances adapted for medical use; dietetic food preparations adapted for medical use; dietary supplements for human beings; food for babies.

Goods & Services

Pharmaceutical preparations; medical preparations; dietetic substances adapted for medical use; dietetic food preparations adapted for medical use; dietary supplements for human beings; food for babies.

Abstract

The invention provides a fulvestrant composition comprising a pharmaceutically acceptable vehicle and not more than 2% total impurities and which, optionally, is free of a non-aqueous ester solvent. The composition may be used to treat hormone receptor positive metastatic breast cancer in a subject.

IPC Classes  ?

• A61K 31/565 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
• A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Goods & Services

(1) Apparatus for recording, transmission, processing and reproduction of data; computer software for use in collection, control, and usage of blood and blood plasma processing equipment and products (2) Blood and plasma apparatus and instruments for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for separating constituents of bodily fluids; blood and plasma apparatus and instruments consisting primarily of plastic tubing and containers all sold as components of blood and plasma kits for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; apparatus and instruments for separating constituents of bodily fluids consisting of plastic tubing and containers all sold as components of blood and plasma kits for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for testing and treating blood; surgical and medical apparatus and instruments for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; replacement parts for all of the aforesaid goods.

Goods & Services

(1) Apparatus for recording, transmission, processing and reproduction of data; computer software for use in collection, control, and usage of blood and blood plasma processing equipment and products (2) Blood and plasma apparatus and instruments for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for separating constituents of bodily fluids; blood and plasma apparatus and instruments consisting primarily of plastic tubing and containers all sold as components of blood and plasma kits for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; apparatus and instruments for separating constituents of bodily fluids consisting of plastic tubing and containers all sold as components of blood and plasma kits for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for testing and treating blood; surgical and medical apparatus and instruments for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; replacement parts for all of the aforesaid goods

Abstract

An injection device may include a container body configured to contain a pharmaceutical material and a film disposed over the container body. The film may have a beveled or rounded corner. The beveled or rounded corner may have a different shape than two other corners of the film. The film may be a label having indicia pertaining to the pharmaceutical material. The container may include a plunger rod extending through the container body and being configured to push the pharmaceutical material out of the container body. The injection device may be received in a shell for packaging. The beveled or rounded corner of the film may limit or prevent the film from peeling and/or curling up from the container body to ensure that the injection device properly fits into the shell.

IPC Classes  ?

• B65D 77/02 - Wrapped articles enclosed in rigid or semi-rigid containers
• A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests
• B65B 3/00 - Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans or jars
• B65B 5/04 - Packaging single articles
• B65B 53/02 - Shrinking wrappers, containers, container covers or container cover securing members during or after packaging by heat
• B65B 61/02 - Auxiliary devices, not otherwise provided for, for operating on sheets, blanks, webs, binding material, containers or packages for perforating, scoring, or applying code or date marks on material prior to packaging
• B65D 75/00 - Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers

Abstract

An injection device may include a container body configured to contain a pharmaceutical material and a film disposed over the container body. The film may have a beveled or rounded corner. The beveled or rounded corner may have a different shape than two other corners of the film. The film may be a label having indicia pertaining to the pharmaceutical material. The container may include a plunger rod extending through the container body and being configured to push the pharmaceutical material out of the container body. The injection device may be received in a shell for packaging. The beveled or rounded corner of the film may limit or prevent the film from peeling and/or curling up from the container body to ensure that the injection device properly fits into the shell.

IPC Classes  ?

• A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests
• A61M 5/178 - Syringes
• A61M 5/50 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
• A61M 39/20 - Closure caps or plugs for connectors or open ends of tubes
• A61M 5/31 - Syringes Details
• A61M 39/10 - Tube connectors or tube couplings

Abstract

A fluid delivery system includes a fluid pump and a fluid management system. The fluid management system receives input indicating a fluid (such as including a drug, a therapy, etc.) of a particular type to be delivered to a recipient. The fluid management system maps the particular type of the fluid to a set of patient parameters to be monitored during the delivery of the fluid to the recipient. During delivery of the particular fluid to the recipient, the fluid management system monitors feedback from the recipient for each of the patient parameters in the set. Based on the feedback, the fluid management system controls the delivery of the fluid to the recipient.

IPC Classes  ?

• A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
• A61M 5/142 - Pressure infusion, e.g. using pumps

Abstract

A medical container and pharmaceutical product include a chamber containing a medical fluid and a connector secured to the chamber. The connector includes a connector element extending between a first end and a second end, and an inner lumen is defined between the first end and the second end. The connector element includes a fastening section, a pinch-off section extending from the fastening section, a head section extending from the pinch-off section, and a deflection element. The head section includes a locking rim and another rim that extends radially beyond the locking rim. The deflection element is directly connected to and extends from the another rim. The deflection element terminates at an end that extends into a portion of the inner lumen defined by the pinch-off section to protect the pinch-off section without hindering pinching of the pinch-off section.

IPC Classes  ?

• A61J 1/14 - Containers specially adapted for medical or pharmaceutical purposes DetailsAccessories therefor
• A61J 1/10 - Bag-type containers
• A61J 1/18 - Arrangements for indicating condition of container contents, e.g. sterile condition
• A61M 39/20 - Closure caps or plugs for connectors or open ends of tubes

Abstract

The present invention provides a formulation that includes a therapeutically effective amount of ephedrine or a pharmaceutically acceptable salt thereof, and a method for preparing the formulation. In some embodiments, the formulation includes a tonicity agent, a citrate buffer, water, and has a pH of about 5.2-5.4. The formulation of the invention is stable and ready-to-administer.

IPC Classes  ?

• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/08 - Solutions
• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61M 5/31 - Syringes Details

Abstract

A first fluid delivery assembly includes a transparent display screen and a display screen controller. The display screen controller: i) receives input indicating a detected orientation of the transparent display screen, and ii) controls operation of the transparent display screen depending upon the orientation. A second fluid assembly includes a display screen assembly including: i) a first display screen facing a first direction with respect to the display screen assembly, and ii) a second display screen facing a second direction with respect to the display screen assembly. The second direction is different than the first direction. The second liquid delivery system further includes an image capturing device and a display screen controller. The image capturing device captures an image of an object disposed behind the first display screen. The display screen controller displays the image of the object on the first display screen of the display screen assembly.

IPC Classes  ?

• A61M 5/145 - Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
• G06F 3/147 - Digital output to display device using display panels

Goods & Services

Pharmaceutical preparations, namely, irrigation solutions for flushing, rinsing and cleansing of tissues, body cavities, and wounds; Medical instruments, namely, medical containers and medical bags sold filled with medical liquids and solutions, namely irrigation solutions

Abstract

The invention provides a liquid formulation comprising bupivacaine or a pharmaceutically acceptable salt thereof, a method for preparing the formulation, and a product which includes the formulation. The formulation of the invention may include a tonicity agent, and has an initial pH of from about 4.2 to about 4.5. The formulation of the invention is stable and ready-to-administer.

IPC Classes  ?

• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/08 - Solutions
• A61K 31/445 - Non-condensed piperidines, e.g. piperocaine
• A61K 47/02 - Inorganic compounds
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
• A61J 1/10 - Bag-type containers

Abstract

The invention provides a liquid formulation comprising bupivacaine or a pharmaceutically acceptable salt thereof, a method for preparing the formulation, and a product which includes the formulation. The formulation of the invention may include a tonicity agent, and has an initial pH of from about 4.2 to about 4.5. The formulation of the invention is stable and ready-to-administer.

IPC Classes  ?

• A61K 31/445 - Non-condensed piperidines, e.g. piperocaine
• A61K 47/02 - Inorganic compounds

Goods & Services

Pharmaceutical preparations, namely, electrolyte free infusion solutions for central intravenous nutritional therapy; pharmaceutical preparations, namely, electrolyte free infusion solutions for central intravenous parenteral nutrition

Goods & Services

Pharmaceutical preparations, namely, electrolyte free infusion solutions for central intravenous nutritional therapy; pharmaceutical preparations, namely, electrolyte free infusion solutions for central intravenous parenteral nutrition

Goods & Services

Surgical instruments and apparatus; Medical apparatus and instruments.

Abstract

The present disclosure describes a syringe assembly including a syringe and an oxygen scavenger syringe cap disposed over a connection of the syringe, the oxygen scavenger syringe cap having a main body that defines a proximal end defining an opening, a distal end opposite the proximal end along the axial direction, an outer surface, and an inner surface opposite the outer surface that defines a passage to receive a tip cap and the connection, where the oxygen scavenger syringe cap is spaced from the tip cap. The oxygen scavenger syringe cap further includes an oxygen absorber.

IPC Classes  ?

• A61M 5/315 - PistonsPiston-rodsGuiding, blocking or restricting the movement of the rodAppliances on the rod for facilitating dosing
• A61M 5/31 - Syringes Details

Goods & Services

Downloadable computer software for calculating, evaluating, determining, and administering nutrition to patients for use in the medical field of compounding and parenteral nutrition Medical instruments for use in parenteral feeding, parenteral feeding mixers, tubes, and pumps Providing temporary use of on-line non-downloadable software for calculating, evaluating, determining, and administering nutrition to patients for use in the medical field of compounding and parenteral nutrition

Abstract

A system (1) for monitoring critical pharmaceutical operations comprises an enclosure (10) defining an interior space (100), at least one camera (11) installed so as to record image frames (F) of the interior space (100), and a controller (12), wherein the controller (12) is configured to: receive the image frames (F) recorded by the at least one camera (11), analyse the image frames (F) to detect an event captured by one or more of the image frames (F), using a first model perform a classification of an intervention captured by the one or more of the image frames (F) using a second model (ML 2), the second model (ML 2) being trained with image frames of interventions assigned to at least two different classes, and provide a notification (N) indicating one of the at least two different classes based on the classification.

IPC Classes  ?

• G06V 10/25 - Determination of region of interest [ROI] or a volume of interest [VOI]
• G06V 10/764 - Arrangements for image or video recognition or understanding using pattern recognition or machine learning using classification, e.g. of video objects
• G06V 20/40 - ScenesScene-specific elements in video content
• G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms

Goods & Services

Apparatus for recording, transmission, processing and reproduction of data; computer software for use in collection, control, and usage of blood and blood plasma processing equipment and products. Blood and plasma apparatus and instruments for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for separating constituents of bodily fluids; blood and plasma apparatus and instruments consisting primarily of plastic tubing and containers all sold as components of blood and plasma kits for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; apparatus and instruments for separating constituents of bodily fluids consisting of plastic tubing and containers all sold as components of blood and plasma kits for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for testing and treating blood; surgical and medical apparatus and instruments for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; replacement parts for all of the aforesaid goods.

Goods & Services

Apparatus for recording, transmission, processing and reproduction of data; computer software for use in collection, control, and usage of blood and blood plasma processing equipment and products Blood and plasma apparatus and instruments for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for separating constituents of bodily fluids; blood and plasma apparatus and instruments consisting primarily of plastic tubing and containers all sold as components of blood and plasma kits for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; apparatus and instruments for separating constituents of bodily fluids consisting of plastic tubing and containers all sold as components of blood and plasma kits for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for testing and treating blood; surgical and medical apparatus and instruments for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; replacement parts for all of the aforesaid goods

Goods & Services

Apparatus for recording, transmission, processing and reproduction of data; computer software for use in collection, control, and usage of blood and blood plasma processing equipment and products Blood and plasma apparatus and instruments for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for separating constituents of bodily fluids; blood and plasma apparatus and instruments consisting primarily of plastic tubing and containers all sold as components of blood and plasma kits for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; apparatus and instruments for separating constituents of bodily fluids consisting of plastic tubing and containers all sold as components of blood and plasma kits for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; medical apparatus and instruments for testing and treating blood; surgical and medical apparatus and instruments for withdrawing whole blood, separating the blood into constituents and returning at least some of the constituents to the donor or patient; replacement parts for all of the aforesaid goods

Goods & Services

Downloadable computer software for calculating, evaluating, determining, and administering nutrition to patients for use in the medical field of compounding and parenteral nutrition. Medical instruments for use in parenteral feeding, parenteral feeding mixers, tubes, and pumps Providing temporary use of on-line non-downloadable software and applications for calculating, evaluating, determining, and administering nutrition to patients for use in the medical field of compounding and parenteral nutrition

Goods & Services

Downloadable computer software for calculating, evaluating, determining, and administering nutrition to patients for use in the medical field of compounding and parenteral nutrition Medical apparatus and instruments, namely, parenteral feeding mixers, tubes andpumps for use in the medical area Providing temporary use of online non-downloadable computer software forcalculating, evaluating, determining, and administering nutrition to patients for usein the medical field of compounding and parenteral nutrition.

Goods & Services

Downloadable computer software for calculating, evaluating, determining, and administering nutrition to patients for use in the medical field of compounding and parenteral nutrition Medical apparatus and instruments, namely, parenteral feeding mixers, tubes and pumps for use in the medical area Providing temporary use of online non-downloadable computer software for calculating, evaluating, determining, and administering nutrition to patients for use in the medical field of compounding and parenteral nutrition.

Abstract

The present invention relates to an aqueous pharmaceutical composition for parenteral administration to a human, comprising a pharmacologically effective amount of a pharmaceutically acceptable vitamin K, a polyethoxylated castor oil as solubilizer, and a citrate buffer at a concentration of 1 to 40 mmol/L, wherein the pH of the composition is between 3.5 and 7.0, to a pharmaceutically acceptable container comprising the composition, and to the composition for use in the treatment or prevention of vitamin K deficiency and/or haemorrhage or for use as an antidote to anticoagulants of the coumarin type as well as to a method for preparing the composition.

IPC Classes  ?

• A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
• A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Abstract

An infusion system includes an infusion endpoint configured to deliver a medical fluid and a broadcaster configured to communicate with the infusion endpoint. The infusion endpoint includes a controller and a communication module configured to communicate using first and second communication mediums. The broadcaster includes a wireless transmitter and a computing device configured to provide a broadcasting utility. The broadcasting utility is configured to prepare a message for broadcast by the wireless transmitter, and the communication module is configured to receive the message via a wireless link using the first communication medium. The controller is configured to determine one or more configuration parameters from the message, connect to a network according to the configuration parameters and disable the first communication medium when connected to the network. The communication module is configured to communicate with the network via a network link using the second communication medium.

IPC Classes  ?

• A61M 5/142 - Pressure infusion, e.g. using pumps

Abstract

The invention provides a liquid formulation comprising norepinephrine or a pharmaceutically acceptable salt thereof. The formulation invention includes an antioxidant, an isotonicity agent, and has a pH of about 3.0-3.8. The liquid formulation according to the invention is stable and ready-to-administer.

IPC Classes  ?

• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61J 1/10 - Bag-type containers
• A61J 1/14 - Containers specially adapted for medical or pharmaceutical purposes DetailsAccessories therefor
• A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids

Abstract

The invention provides a liquid formulation comprising epinephrine or a pharmaceutically acceptable salt thereof. The formulation invention includes ascorbic acid and/or a pharmaceutically acceptable salt thereof, an isotonicity agent, and has a pH of about 3.0-5.0. The liquid formulation according to the invention is stable and ready-to-administer.

IPC Classes  ?

• A61K 31/13 - Amines, e.g. amantadine
• A61K 31/135 - Amines, e.g. amantadine having aromatic rings, e.g. methadone
• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61K 9/08 - Solutions
• A61K 31/30 - Copper compounds

Goods & Services

Pharmaceutical preparations; Medical preparations; Dietetic substances for medical use; Dietetic food for medical use; Dietary supplements for humans; food for babies.

Goods & Services

Pharmaceutical preparations; Medical preparations; Dietetic substances for medical use; Dietetic food for medical use; Dietary supplements for humans; food for babies.

Goods & Services

Pharmaceutical preparations in medical containers, namely, standard pharmaceutical solutions for drug reconstitution and drug preparation, with the exception of pharmaceutical oncological products; pharmaceutical preparations, namely, additives in the nature of vitamins or antibiotics for standard solutions for drug reconstitution and drug preparation, with the exception of oncological pharmaceutical additive solutions Medical instruments and apparatus, namely, medical container, medical bags, medical bottles for medical standard solutions; Pvc-free packaging materials, namely, Pvc-free plastic infusion bags, bottles for use in storing medical standard solutions; medical instruments and apparatus, namely, adapters and connecting parts for drug preparation and drug reconstitution; medical instruments and apparatus, namely, adapters and connecting parts for medical container, medical bags, medical bottles for the administration of additives to medical standard solutions

Abstract

The present invention is directed to a pharmaceutical product which includes a liquid formulation comprising levothyroxine or a pharmaceutically acceptable salt thereof. The formulation of the present invention includes a cyclodextrin, water, and an amine, and has a pH above the buffering range of the amine. The liquid formulation of the invention is stable and ready-to-use.

IPC Classes  ?

• A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/08 - Solutions
• A61K 33/18 - IodineCompounds thereof
• A61K 47/02 - Inorganic compounds
• A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids

Goods & Services

Dietetic foods adapted for infants; dietetic preparations adapted for medical use; pharmaceutical preparations for human use.

Abstract

A method includes calculating a volume of fluid in a pumping chamber when the chamber is not full or empty based on pressure and temperature measurements taken during a negative full-volume state, a positive full-volume state, and an empty-volume state, and an infusion system includes a controller configured to carry out such calculation. Such method, or a separate method, may measure temperature and pressure of a common volume and a pumping chamber, wherein the pressure is measured using a pressure sensor and the temperature is measured using a temperature sensor, optionally one that measures the temperature of the pressure sensor, and calculate a volume of fluid in the pumping chamber based on ideal gas law and the pressure and temperature measurements, and such infusion system, or a separate system, includes a controller configured to carry out such measurement and calculation.

IPC Classes  ?

• A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
• F04B 43/02 - Machines, pumps, or pumping installations having flexible working members having plate-like flexible members, e.g. diaphragms
• F04B 51/00 - Testing machines, pumps, or pumping installations
• G01M 99/00 - Subject matter not provided for in other groups of this subclass

Abstract

A method includes calculating a volume of fluid in a pumping chamber when the chamber is not full or empty based on pressure and temperature measurements taken during a negative full-volume state, a positive full-volume state, and an empty-volume state, and an infusion system includes a controller configured to carry out such calculation. Such method, or a separate method, may measure temperature and pressure of a common volume and a pumping chamber, wherein the pressure is measured using a pressure sensor and the temperature is measured using a temperature sensor, optionally one that measures the temperature of the pressure sensor, and calculate a volume of fluid in the pumping chamber based on ideal gas law and the pressure and temperature measurements, and such infusion system, or a separate system, includes a controller configured to carry out such measurement and calculation.

IPC Classes  ?

• A61M 5/145 - Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons

Abstract

The invention relates to a rocuronium composition providing no or less vascular pain to patients upon injection. The rocuronium composition has a pH of 2.5 to 3.5 and a titratable acidity of not more than 35 mEq. The rocuronium composition is stable upon thermal sterilization. Further, the rocuronium composition is stable upon storage at room-temperature.

IPC Classes  ?

• A61K 31/58 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/08 - Solutions
• A61K 47/02 - Inorganic compounds
• A61P 21/02 - Muscle relaxants, e.g. for tetanus or cramps
• A61P 23/00 - Anaesthetics

Abstract

An infusion system includes an infusion device, an infusion set, and a sensor assembly. The infusion device includes a syringe including a barrel with an outlet end and a plunger, and a pusher device in engagement with the plunger. The set occludes an infusion line having a first end in communication with the outlet end of the barrel and a second end, and a backpressure regulator disposed between the first end and the second end of the infusion line. The sensor assembly includes a first sensor disposed along the infusion line between the backpressure regulator and the second end of the infusion line. The infusion device also includes a controller coupled to the sensor assembly.

IPC Classes  ?

• A61M 5/145 - Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
• A61M 5/168 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters

Abstract

Machine learned neural networks or machine learning algorithms may be used in a variety of healthcare methods and systems, such as those relating to drug delivery, drug therapies, and/or infusion pumps. The machine-learned neural networks may receive and process data to provide one or more outputs, such as recommended dose limit settings, potential adverse events, medication misuses, occlusion occurrences, extravasations and/or disconnections, pump failures, and maintenance needs. The machine learning algorithms may be trained on a corpus of relevant data to identify recommended dose limit settings, potential adverse events, medication misuses, occlusion occurrences, extravasations and/or disconnections, pump failures, and maintenance needs.

IPC Classes  ?

• G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
• G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
• G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
• G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Goods & Services

Medical needles and safety protectors for medical needles.

Goods & Services

Dietary and nutritional supplements comprised of a balanced mixture of nine trace elements, namely, iron, molybdenum, chromium, zinc, fluoride, iodine, manganese, selenium and copper for parenteral nutrition

Goods & Services

Downloadable computer software for calculating, evaluating, determining, and administering nutrition to patients for use in the medical field of compounding and parenteral nutrition. Providing temporary use of online non-downloadable computer software for calculating, evaluating, determining, and administering nutrition to patients for use in the medical field of compounding and parenteral nutrition.

Goods & Services

medical needles and safety protectors for medical needles

Abstract

The present invention provides a formulation that includes a therapeutically effective amount of phenylephrine or a pharmaceutically acceptable salt thereof, and a method for preparing the formulation. In some embodiments, the formulation includes a tonicity agent, a citrate buffer, water, and has an initial pH of from 5.6 to 6.0. In other embodiments, the formulation includes a tonicity agent, a citrate buffer, an antioxidant, water, and has an initial pH of from 3.6 to 4.8. The formulation of the invention is sterile, stable, ready-to-administer and packaged into a polymeric syringe.

IPC Classes  ?

• A61K 9/08 - Solutions
• A61K 31/05 - Phenols
• A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
• A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Abstract

Provided is a process for preparing an emulsion having an oil phase containing an emulsifier, an oil, a drug, and a co-emulsifier, and an aqueous phase containing water, a tonicity agent, and a pH modifier, without removing excess co-emulsifier after emulsification. The process includes emulsifying an oil phase containing an oil, aprepitant, an egg lecithin, and ethanol, and an aqueous phase containing water, sucrose, and oleic acid or salt thereof, without removing ethanol after emulsification. The drug is added to the oil phase as a dry mixture containing the drug and a co-emulsifier (e g., ethanol).

IPC Classes  ?

• A61K 9/107 - Emulsions
• A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
• A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
• A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
• A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
• A61K 47/46 - Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Goods & Services

Pharmaceutical preparations for human use, excluding tea and tea products; Dietetic substances adapted for medical use, excluding tea and tea products; food for babies.

Abstract

The present invention provides a formulation that includes a therapeutically effective amount of ephedrine or a pharmaceutically acceptable salt thereof, and a method for preparing the formulation. In some embodiments, the formulation includes a tonicity agent, a citrate buffer, water, and has a pH of about 5.2-5.4. The formulation of the invention is stable and ready-to-administer.

IPC Classes  ?

• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61M 5/31 - Syringes Details

Goods & Services

Radio frequency identification tagged pharmaceutical products, namely, anesthetics for surgical and non-surgical use, analgesics, anti-infectives, antiemetics; Radio frequency identification tagged pharmaceutical products, namely, radiological, magnetic resonance imaging, and ultrasound contrast agents for diagnostic and imaging procedures for medical purposes; Radio frequency identification tagged pharmaceutical products, namely, sedatives; Radio frequency identification tagged pharmaceutical products, namely, cardiovascular pharmaceuticals; Radio frequency identification tagged pharmaceutical products, namely, oncology pharmaceuticals being pharmaceutical preparations and substances for the treatment of cancer and for the treatment of tumors; Radio frequency identification tagged pharmaceutical products, namely, critical care pharmaceuticals being essential to the management of critically and chronically ill patients, being anticoagulants, anti-inflammatory pharmaceuticals, hormones, electrolyte injection solutions for medical use and pharmaceuticals acting on the central nervous system; Radio frequency identification tagged pharmaceutical products, namely, diluents for medical purposes, in the nature of sodium chloride injection solutions, dextrose injection solutions, lactated ringer's injection solutions, and sterile water for injection.

Abstract

A fluid delivery system displays, on a display screen, fluid identifiers including a first fluid identifier indicating a first fluid and a second fluid identifier specifying a second fluid. The fluid delivery system further displays, on the display screen, a first indication of receiving an excessive number of fluid delivery pump programming alerts associated with the first fluid identifier. The fluid delivery system adjusts a first fluid delivery limit setting associated with delivery of the first fluid in response to the excessive number of fluid delivery pump programming alerts associated with the first fluid identifier. The fluid delivery system implements the adjusted first fluid delivery limit setting for each of multiple fluid delivery pumps subsequently requesting to deliver the first fluid to a respective recipient.

IPC Classes  ?

• G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
• A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic

Abstract

A fluid delivery system displays, on a display screen, fluid identifiers including a first fluid identifier indicating a first fluid and a second fluid identifier specifying a second fluid. The fluid delivery system further displays, on the display screen, a first indication of receiving an excessive number of fluid delivery pump programming alerts associated with the first fluid identifier. The fluid delivery system adjusts a first fluid delivery limit setting associated with delivery of the first fluid in response to the excessive number of fluid delivery pump programming alerts associated with the first fluid identifier. The fluid delivery system implements the adjusted first fluid delivery limit setting for each of multiple fluid delivery pumps subsequently requesting to deliver the first fluid to a respective recipient.

IPC Classes  ?

• G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
• G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
• G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

Goods & Services

Pharmaceutical preparations; Dietetic substances adapted for medical use; Vitamin preparations; Vitamins for intravenous administration; vitamins for use in clinical nutrition.

Goods & Services

Pharmaceutical preparations; Dietetic substances adapted for medical use; Vitamin preparations; Vitamins for intravenous administration; vitamins for use in clinical nutrition.

Goods & Services

Vitamins for intravenous administration.

Goods & Services

Pharmaceutical preparations; Dietetic substances adapted for medical use; Vitamin preparations; Vitamins for intravenous administration; vitamins for use in clinical nutrition.

Goods & Services

Pharmaceutical preparations; nutritional solutions for medical use for intravenous administration; dietetic substances for medical use; food for babies.

Goods & Services

Pharmaceutical preparations; nutritional solutions for medical use for intravenous administration; dietetic substances for medical use; food for babies.

Goods & Services

Pharmaceutical preparations; nutritional solutions for medical use for intravenous administration; dietetic substances for medical use; food for babies.

Goods & Services

(1) Pharmaceutical preparations; nutritional solutions for medical use for intravenous administration; dietetic substances for medical use; food for babies.

Goods & Services

(1) Pharmaceutical preparations; nutritional solutions for medical use for intravenous administration; dietetic substances for medical use; food for babies.

Goods & Services

(1) Pharmaceutical preparations; nutritional solutions for medical use for intravenous administration; dietetic substances for medical use; food for babies.

Abstract

A connector for a medical container is described. The connector includes a connector element defining an inner lumen extending axially from a first end of the connector element to a second end of the connector element that is opposite the first end. The connector element includes a fastening section at the first end of the connector element that is secured to the medical container, a pinch-off section extending from the fastening section towards the second end of the connector element, a head section extending from the pinch-off section towards the second end of the connector element, and a deflection element extending from the head section towards the first end of the connector element.

IPC Classes  ?

• A61J 1/14 - Containers specially adapted for medical or pharmaceutical purposes DetailsAccessories therefor
• A61J 1/10 - Bag-type containers
• A61J 1/18 - Arrangements for indicating condition of container contents, e.g. sterile condition
• A61M 39/20 - Closure caps or plugs for connectors or open ends of tubes

Abstract

The present invention relates to lactulose for use in treatment of Clostridioides difficile infection (CDI) and/or prevention of recurrence of CDI or a condition associated with CDI. Furthermore, the invention relates to a therapeutic combination comprising lactulose and a therapeutically effective amount of one or more antibiotic for use in treatment of Clostridioides difficile infection (CDI) and/or prevention of recurrence of CDI or a condition associated with CDI.

IPC Classes  ?

• A61K 31/4164 - 1,3-Diazoles
• A61K 31/437 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
• A61K 31/7016 - Disaccharides, e.g. lactose, lactulose
• A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
• A61K 38/14 - Peptides containing saccharide radicalsDerivatives thereof
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61P 31/04 - Antibacterial agents

Goods & Services

Downloadable computer software for use in the medical field, namely, for use on hospital servers for operation of infusion therapy machines and for reporting infusion and nutrition information and data

Goods & Services

Surgical and medical apparatus and instruments for use in general surgery; patient monitoring apparatus and instruments, namely, patient monitors for critical care and anesthesia; patient medical monitors for monitoring analgesia; medical apparatus and instruments for monitoring anesthesia and analgesia; the aforementioned goods explicitly not for medical equipment and apparatus for supplying oxygen to human beings, for respiration, for oxygen therapy, for inhalers, for apparatus for artificial respiration or for medical apparatus for measuring oxygen concentration in the blood

Abstract

A package includes a tray having a plurality of openings and a plurality of barrel covers. Each of the plurality of barrel covers extend through one of the plurality of openings. A tub can receive the tray. A plurality of tamper evident devices can be attached to the plurality of barrel covers. Each tamper evident device includes a collar, a tamper evident cap, and a frangible connection between the collar and the tamper evident cap. A method of packaging a plurality of syringe bodies includes inserting the plurality of syringe bodies into a plurality of barrel covers positioned in a tray, and inserting the tray into a tub.

IPC Classes  ?

• A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests
• A61M 5/32 - NeedlesDetails of needles pertaining to their connection with syringe or hubAccessories for bringing the needle into, or holding the needle on, the bodyDevices for protection of needles

Abstract

The present disclosure describes a syringe assembly including a syringe and an oxygen scavenger syringe cap disposed over a connection of the syringe, the oxygen scavenger syringe cap having a main body that defines a proximal end defining an opening, a distal end opposite the proximal end along the axial direction, an outer surface, and an inner surface opposite the outer surface that defines a passage to receive a tip cap and the connection, where the oxygen scavenger syringe cap is spaced from the tip cap. The oxygen scavenger syringe cap further includes an oxygen absorber.

IPC Classes  ?

• A61M 5/32 - NeedlesDetails of needles pertaining to their connection with syringe or hubAccessories for bringing the needle into, or holding the needle on, the bodyDevices for protection of needles
• A61M 5/31 - Syringes Details

Abstract

A system (1) for monitoring critical pharmaceutical operations comprises an enclosure (10) defining an interior space (100), at least one camera (11) installed so as to record image frames (F) of the interior space (100), and a controller (12), wherein the controller (12) is configured to: receive the image frames (F) recorded by the at least one camera (11), analyse the image frames (F) to detect an event captured by one or more of the image frames (F), using a first model perform a classification of an intervention captured by the one or more of the image frames (F) using a second model (ML 2), the second model (ML 2) being trained with image frames of interventions assigned to at least two different classes, and provide a notification (N) indicating one of the at least two different classes based on the classification.

IPC Classes  ?

• G06V 20/40 - ScenesScene-specific elements in video content

Abstract

The present invention provides a formulation that includes a therapeutically effective amount of ephedrine or a pharmaceutically acceptable salt thereof, and a method for preparing the formulation. In some embodiments, the formulation includes a tonicity agent, a citrate buffer, water, and has a pH of about 5.2-5.4. The formulation of the invention is stable and ready-to-administer.

IPC Classes  ?

• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
• A61K 47/12 - Carboxylic acidsSalts or anhydrides thereof
• A61K 47/02 - Inorganic compounds

Abstract

The invention provides a liquid formulation comprising norepinephrine or a pharmaceutically acceptable salt thereof. The formulation invention includes an antioxidant, an isotonicity agent, and has a pH of about 3.0-3.8. The liquid formulation according to the invention is stable and ready-to-administer.

IPC Classes  ?

• A61K 31/13 - Amines, e.g. amantadine
• A61K 31/135 - Amines, e.g. amantadine having aromatic rings, e.g. methadone
• A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

Abstract

A system for validating a system for monitoring pharmaceutical operations includes at least one controller configured to perform a classification of an intervention captured by one or more image frames using a classification model, the classification model being trained with image frames of interventions assigned to at least two different classes. The at least one controller is also configured to assign a value to an individual feature of a feature set associated with the classification, the value corresponding to a contribution of the individual feature to the classification. In addition, the at least one controller is configured to generate a graphical representation of the values for the features contributing to the classification of the interventions.

IPC Classes  ?

• G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
• G16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
• G06V 10/764 - Arrangements for image or video recognition or understanding using pattern recognition or machine learning using classification, e.g. of video objects
• G06V 10/50 - Extraction of image or video features by performing operations within image blocksExtraction of image or video features by using histograms, e.g. histogram of oriented gradients [HoG]Extraction of image or video features by summing image-intensity valuesProjection analysis

Goods & Services

Pharmaceuticals; Nutritional solutions for medical use for intravenous administration; Dietetic substances for medical use; Food for babies.

Goods & Services

Pharmaceuticals; Nutritional solutions for medical use for intravenous administration; Dietetic substances for medical use; Food for babies.

Goods & Services

Pharmaceutical preparations; Nutritional solutions for medical use for intravenous administration; Dietetic substances for medical use; Food for babies.

Goods & Services

Pharmaceuticals; Nutritional solutions for medical use for intravenous administration; Dietetic substances for medical use; Food for babies.

Goods & Services

Pharmaceuticals; Nutritional solutions for medical use for intravenous administration; Dietetic substances for medical use; Food for babies.

Goods & Services

Pharmaceutical preparations, namely, infusion solutions for central and peripheral intravenous nutritional therapy and infusion solutions for central and peripheral intravenous parenteral nutrition

Abstract

The present invention relates to an aqueous pharmaceutical composition for parenteral administration to a human, comprising a pharmacologically effective amount of a pharmaceutically acceptable vitamin K, a polyethoxylated castor oil as solubilizer, and a citrate buffer at a concentration of 1 to 40 mmol/L, wherein the pH of the composition is between 3.5 and 7.0, to a pharmaceutically acceptable container comprising the composition, and to the composition for use in the treatment or prevention of vitamin K deficiency and/or haemorrhage or for use as an antidote to anticoagulants of the coumarin type as well as to a method for preparing the composition.

IPC Classes  ?

• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
• A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
• A61K 9/08 - Solutions
• A61K 9/10 - DispersionsEmulsions

Abstract

A liquid delivery system includes an air elimination assembly disposed in a pathway between a liquid source and a recipient. As its name suggests, the air elimination assembly removes gas from the liquid as it flows between an input port and output port of the air elimination assembly. A magnitude of pressure at the gas output port of the air elimination assembly is controlled to expel gas from the liquid passing from the input port to the output port. The gas expelled from the liquid is outputted from the gas output port. The liquid delivered to the recipient is void of any gases.

IPC Classes  ?

• F04B 43/06 - Pumps having fluid drive
• F04B 53/16 - CasingsCylindersCylinder liners or headsFluid connections

Goods & Services

Pharmaceutical preparations, namely, infusion solutions for central and peripheral intravenous nutritional therapy and infusion solutions for central and peripheral intravenous parenteral nutrition

Goods & Services

(1) Medical devices for dosage, measuring and monitoring, namely, drug delivery devices in the nature of infusion pumps for delivering medications and fluids to patients; medical devices for dosage, measuring and monitoring, namely, drug delivery devices in the nature of drug delivery infusion systems comprised of pumps, computer hardware and software, and disposable tubing and related parts and accessories, for delivery of medications and fluids to patients

Abstract

The present invention relates to a highly efficient method for producing oil-in-water emulsions, preferably for parenteral administration, which method is characterized in that large parts of the water phase are added only after the energy-intensive homogenization of the pre-emulsion, i.e. an emulsion having low water content is first produced and said emulsion is subsequently “diluted”.

IPC Classes  ?

• A61K 9/107 - Emulsions
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Abstract

Provided are methods for analyzing and purifying degarelix or a pharmaceutically acceptable salt thereof containing at least one related impurity. Also provided are methods for analyzing and purifying degarelix or a pharmaceutically acceptable salt thereof containing compound A and/or compound D as an impurity. Further provided are degarelix or a pharmaceutically acceptable salt thereof prepared from and/or selected using the disclosed methods.

IPC Classes  ?

• C07K 1/16 - ExtractionSeparationPurification by chromatography
• G01N 33/76 - Human chorionic gonadotropin
• C07K 14/59 - Follicle-stimulating hormone [FSH]Chorionic gonadotropins, e.g. hCG [human chorionic gonadotropin]Luteinising hormone [LH]Thyroid-stimulating hormone [TSH]
• B01J 20/26 - Synthetic macromolecular compounds
• B01D 15/42 - Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution

Goods & Services

Pharmaceutical preparations, namely, infusion solutions for central intravenous nutritional therapy and infusion solutions for central intravenous parenteral nutrition

Goods & Services

Pharmaceutical preparations, namely, infusion solutions for peripheral intravenous nutritional therapy and infusion solutions for peripheral intravenous parenteral nutrition

Abstract

The invention relates to a rocuronium composition providing no or less vascular pain to patients upon injection. The rocuronium composition has a pH of 2.5 to 3.5 and a titratable acidity of not more than 35 mEq. The rocuronium composition is stable upon thermal sterilization. Further, the rocuronium composition is stable upon storage at room-temperature.

IPC Classes  ?

• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/08 - Solutions
• A61K 47/02 - Inorganic compounds
• A61K 31/00 - Medicinal preparations containing organic active ingredients
• A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system

Goods & Services

Pharmaceutical preparations; medical preparations; dietetic food and substances for medical use; dietetic food and substances in liquid, powder and solid form for medical use; food for babies; dietary supplements.

Goods & Services

Education and training services; educational support programs for patients, caregivers and health care professionals; instructional services for patients, caregivers and health care professionals; Providing on-line publications; publishing (online) of publications in the field of medicine and nutrition; Physical fitness instruction; providing on-line cooking videos, not downloadable; Organization and conduction of lectures, courses, congresses, exhibitions, conferences, seminars and symposiums for educational and instructive purposes; Provision of non-downloadable videos. Medical and health care services for human beings; providing information in the field of health via a website; nutritional advisory and consultation services; advisory, information and consultancy services in the medical area, organization of patients.

Goods & Services

Pharmaceutical preparations, namely, infusion solutions for peripheral intravenous nutritional therapy and infusion solutions for peripheral intravenous parenteral nutrition

Goods & Services

Pharmaceutical preparations, namely, infusion solutions for central intravenous nutritional therapy and infusion solutions for central intravenous parenteral nutrition

Abstract

Devices and methods for use with syringes are disclosed. A plunger rod includes an outer housing having proximal and distal ends and a lumen between the ends, as well as an inner body axially slidable within the lumen between a first and second position. The inner body has a retention member extending therefrom. When the inner body is in the first position, the plunger rod has a first length, and, when the inner body is in the second position, the plunger rod has a second length greater than the first length. When the inner body is in the second position, the inner body is configured to be rotated relative to the outer housing until the retention member is received within the outer housing to preclude the inner body from moving in the axial direction.

IPC Classes  ?

• A61M 5/315 - PistonsPiston-rodsGuiding, blocking or restricting the movement of the rodAppliances on the rod for facilitating dosing
• A61M 5/28 - Syringe ampoules or cartridges, i.e. ampoules or cartridges provided with a needle

Goods & Services

Pharmaceutical preparations, namely, irrigation solutions for flushing, rinsing and cleansing of tissues, body cavities, and wounds; Medical instruments, namely, medical containers and medical bags sold filled with medical liquids and solutions, namely irrigation solutions

Goods & Services

Pharmaceutical preparations, namely, irrigation solutions for flushing, rinsing and cleansing of tissues, body cavities, and wounds; Medical instruments, namely, medical containers and medical bags sold filled with medical liquids and solutions, namely irrigation solutions Medical instruments, namely, medical containers and medical bags sold empty for medical liquids and solutions, namely irrigation solutions; Pvc-free packaging materials, namely, Pvc-free plastic bags sold empty for storing medical liquids and solutions for use in hospitals, medical and healthcare settings

Goods & Services

Downloadable electronic publications, namely, newsletters and brochures in the fields of medicine, healthcare, and nutrition Printed matter, namely, newsletters and brochures in the fields of medicine, healthcare, and nutrition Retail pharmacy services and wholesale distributorship services featuring pharmaceutical and medical supplies Medical and health care services for human beings; providing information in the field of health via a website

Abstract

Devices and methods for use with syringes are disclosed. A plunger rod includes an outer housing having proximal and distal ends and a lumen between the ends, as well as an inner body axially slidable within the lumen between a first and second position. The inner body has a retention member extending therefrom. When the inner body is in the first position, the plunger rod has a first length, and, when the inner body is in the second position, the plunger rod has a second length greater than the first length. When the inner body is in the second position, the inner body is configured to be rotated relative to the outer housing until the retention member is received within the outer housing to preclude the inner body from moving in the axial direction.

IPC Classes  ?

• A61M 5/315 - PistonsPiston-rodsGuiding, blocking or restricting the movement of the rodAppliances on the rod for facilitating dosing

Abstract

A system includes: a fluid delivery pump and a network of multiple record management processing nodes. The fluid delivery pump is in communication with one or more of the record management-processing nodes in the network. At least a first record management processing node receives input indicating a fluid delivery event. The fluid delivery event indicates fluid delivery from the fluid delivery pump to a recipient. The record management-processing node identifies code pertinent to the fluid delivery event; the code includes criteria in which to validate the fluid delivery event. In response to validation of the fluid delivery event as specified by the criteria in the code, a resource such as the record management-processing node triggers a transaction associated with the fluid delivery event.

IPC Classes  ?

• A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
• G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
• G06Q 20/10 - Payment architectures specially adapted for electronic funds transfer [EFT] systemsPayment architectures specially adapted for home banking systems
• G16H 10/00 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data
• G16H 40/00 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices
• G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records